Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
Condition: Breast Neoplasms Interventions: Drug: Trilaciclib; Drug: Epirubicin; Drug: Cyclophosphamide; Drug: Paclitaxel; Drug: Docetaxel; Drug: Carboplatin; Drug: Trastuzumab; Drug: Pertuzumab Sponsor: wang shusen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Condition: Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Interventions: Drug: Cadonilimab; Drug: AK117; Drug: Oxaliplatin; Drug: Tegafur-gimeracil-oteracil potassium; Drug: Docetaxel; Drug: 5-Fluorouracil Sponsor: Akeso Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials